Philips, a global leader in health technology, announced the introduction of the industry’s first full-service, at-home, 12-lead electrocardiogram (ECG) solution for use in decentralized clinical trials.
February 11, 2022
Philips Introduces First At-Home, 12-Lead ECG Integrated Solution for Decentralized Clinical Trials
February 11, 2022 – Philips, a global leader in health technology, announced the introduction of the industry’s first…
Read More
A patient receives an echocardiogram
February 11, 2022
Study Finds Higher Risk in Families of Black Patients with Inherited Muscle Disease
February 11, 2022 – Black patients diagnosed with dilated cardiomyopathy (DCM) of unknown cause are more likely to have…
Read More
From left: Peggy Schenck, Administrative Director, Cardiovascular Services, RCH; Denise Palmatier, Director, Cardiac Cath Lab, RCH; Vincent Lee, MD, Cardiothoracic Surgery; Neeraj Bensal, MD, Cardiothoracic Surgery; Jenn Paulo, NP; Nichole Barnard, NP; Shankha Biswas, MD, Cardiothoracic Surgery; Nick Johnson, Vice President, Surgical Services, RCH
February 11, 2022
Riverside Community Hospital Earns Three-Star Rating from The Society of Thoracic Surgeons
February 11, 2022 — Riverside Community Hospital has earned a distinguished three-star rating from The Society of…
Read More
Pop-up sensor in heart
February 11, 2022
‘Pop-up’ Electronic Sensors Could Detect When Individual Heart Cells Misbehave
February 11, 2022 — Engineers at the University of California San Diego have developed a powerful new tool that…
Read More
People who have heart artery-opening procedures, called coronary artery revascularization, experience similar outcomes regardless of gender or race, thus the use of invasive heart procedures should not be limited among women and adults from diverse racial or ethnic groups, according to a new joint guideline from the American College of Cardiology and the American Heart Association, in partnership with the Society for Cardiovascular Angiography and Interventions.
February 11, 2022
American College of Cardiology, American Heart Association Issue Coronary Artery Revascularization Guideline
February 11, 2022 — People who have heart artery-opening procedures, called coronary artery revascularization,…
Read More
The American College of Cardiology will host the 71st Annual Scientific Session & Expo live, in person, in Washington, DC, April 2 – 4, 2022, and provides the opportunity to network with colleagues
By Melinda Taschetta-Millane
February 11, 2022
Keynote Speakers Announced for ACC 2022
The American College of Cardiology will host the 71st Annual Scientific Session & Expo live, in person, in…
Read More
The latest cardiology practice-changing scientific breakthrough, late-breaking study presentations have been announced for the 2022 American College of Cardiology (ACC) meeting.
By Melinda Taschetta-Millane
February 10, 2022
ACC 2022 Late-breaking Clinical Trials Announced
The latest cardiology practice-changing scientific breakthrough, late-breaking study presentations have been announced…
Read More
Chenyang Lu, Fullgraf Professor of Computer Science & Engineering at the McKelvey School of Engineering, Washington University in St. Louis #Fitbit
February 09, 2022
That new Fitbit does more than count steps. It may save your life one day.
Chenyang Lu, a professor of computer science and engineering, is marrying Fitbits with machine learning to predict…
Read More
Northwestern Medicine McHenry Hospital recently achieved a milestone with the completion of the 100th Transcatheter Aortic Valve Replacements (TAVR).
February 09, 2022
Northwestern Suburban Hospitals Celebrate 100th TAVR
Febraury 9, 2022 — Northwestern Medicine McHenry Hospital recently achieved a milestone with the completion of the…
Read More
Lymphatic vessels on the heart
February 09, 2022
Study Identifies VE-cadherin Protein as Key Factor in Maintenance of Lymphatic Vessels Serving the Heart
February 9, 2022 – Scientists at the UNC School of Medicine led a study to advance the understanding of lymphatic…
Read More
Innovative Health, LLC, a specialty cardiology reprocessor, has announced that the company has received clearance to reprocess Boston Scientific’s INTELLAMAP ORION High-Resolution Mapping Catheter.
February 09, 2022
Innovative Health Receives Clearance to Reprocess INTELLAMAP ORION High-Resolution Mapping Catheter
February 9, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, has announced that the company has…
Read More
With the addition of Pulse Wave Doppler [1], Philips has greatly expanded the utility of its Handheld Ultrasound – Lumify – enabling clinicians to quantify blood flow in a wide range of point-of-care diagnostic applications – including cardiology, vascular, abdominal, urology, obstetrics and gynecology.
February 09, 2022
Philips Expands Ultrasound Portfolio with Handheld POCUS
February 9, 2022 — Philips, a global leader in health technology, announced it has expanded its ultrasound portfolio…
Read More
Expression of SARS-CoV-2 receptors in human cardiac PCs in situ: Immunofluorescence stainings showing PCs in the human heart. (A,B) Identification of CD31−CD34+PDGFRβ+ PCs around microvessels. CD31 recognises the vessel lumen, the CD34 labels both the luminal ECs and perivascular PCs, while PDGFRβ labels both PCs and vascular smooth muscle cells (VSMCs) in the arteriole’s tunica media. (C–F) A subset of PDGFRβ+ cardiac PCs express ACE2 (C,D) and CD147 (E,F). α-SMA labels some PCs and arterioles’ VSMCs (C,D)
February 09, 2022
SARS-CoV-2 Spike Protein Binds to Heart’s Vascular Cells Potentially Contributing to Severe Microvascular Damage
February 9, 2022 — A new study has shown how SARS-CoV-2 may contribute to severe microvascular damage seen in severely-…
Read More
Figure 1Recommended Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention. ∗While not marketed in the United States, DCBs are available for clinical use in Canada, with 1-3 months of DAPT recommended. DAPT = dual antiplatelet therapy; LD, limited data. Reprinted from Capodanno D, Alfonso F, Levine GN, Valgimigli M, Angiolillo DJ. ACC/AHA versus ESC guidelines on dual antiplatelet therapy: JACC guideline comparison. J Am Coll Cardiol. 2018;72(23 Pt A):2915-2931, with permission from
February 09, 2022
SCAI Releases Expert Consensus on Gender-specific Considerations in Myocardial Revascularization
February 9, 2022 — A newly released expert consensus statement on sex-specific considerations in myocardial…
Read More
Extracorporeal membrane oxygenation (ECMO) is a lifesaving treatment for critically ill neonates. But there has been little data published on which of these patients are more likely to be readmitted to the hospital later on.
February 08, 2022
Researchers Identify Factors That May Help Predict Which Neonatal ECMO Patients Will Have to Return to the Hospital
February 8, 2022 —  Extracorporeal membrane oxygenation (ECMO) is a lifesaving treatment for critically ill neonates.…
Read More
VitalSight was designed to help the 37 million Americans who have uncontrolled Stage 2 hypertension and live every day with a higher risk of heart attack and stroke
February 08, 2022
VitalSight in the U.S., Hypertension Plus in the U.K., Recognized as Outstanding Health Technology at CES 2022
February 8, 2022 — OMRON Healthcare, Inc., the global leader in remote blood pressure monitoring and personal health…
Read More
A new study is the first to show that a remote cognitive assessment could help with tracking patients with cardiovascular risk. Getty Images
February 07, 2022
Study: Cognitive Assessments Can Help Track Cardio Risk
February 8, 2022 — A new study is the first to show that a remote cognitive assessment could help with tracking…
Read More
SCAI cardiogenic shock classification scale
February 02, 2022
SCAI Releases Updated Expert Consensus on Cardiogenic Shock Classification
February 2, 2022 — The Society for Cardiovascular Angiography and Interventions (SCAI) released an expert consensus…
Read More
By far the two biggest news items from January included the first pig heart transplant into a human patient at the University of Maryland Medical Center, and the FDA clearance of Novarti's inclisiran (Leqvio) twice annual dose injectable LDL lowering drug.
By Dave Fornell, DAIC Editor
February 01, 2022
Most Popular Cardiology Content in January 2022
February 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)…
Read More
AI system is trained to read conventional retinal scans for signs of heart disease
January 31, 2022
AI Can Diagnose Heart Disease By Looking In the Eye of the Patient
January 31, 2022 — Scientists have developed an artificial intelligence (AI) system that can analyze eye scans taken…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now